Jacob S. Shaw

Jacob S. Shaw

Auto-generated profile, based on publicly available information

Jacob S. Shaw

Johns Hopkins University School of Medicine

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in Annals of Internal Medicine
Verified
Journal Article
Open access
MSMichael C. Sneller
Michael C. Sneller
CLC. Jason Liang
C. Jason Liang
AMAdriana R. Marques
Adriana R. Marques
JCJoyce Y. Chung
Joyce Y. Chung
SSSujata M. Shanbhag
Sujata M. Shanbhag
HLH. Clifford Lane
H. Clifford Lane
A substantial proportion of persons who develop COVID-19 experience postacute sequelae of SARS-CoV-2 infection (PASC). This article reports baseline findings from an ongoing longitudinal cohort stu... Visual A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings. A substantial proportion of persons who develop COVID-19 experience postacute sequelae of SARS-CoV-2 infec... Background: A substantial proportion of persons who develop COVID-19 report persistent symptoms after acute illness. Various pathophysiologic mechanisms have been implicated in the pathogenesis of ...

25 August 2022 in Scientific Data
Verified
Journal Article
Open access
PDF file
ANAllison C. Nugent
Allison C. Nugent
ATAdam G. Thomas
Adam G. Thomas
MMMargaret Mahoney
Margaret Mahoney
AGAlison Gibbons
Alison Gibbons
JSJarrod T. Smith
Jarrod T. Smith
JCJoyce Chung
Joyce Chung
The NIMH Healthy Research Volunteer Dataset is a collection of phenotypic data characterizing healthy research volunteers using clinical assessments such as assays of blood and urine, mental health assessments, diagnostic and dimensional measures of mental health, cognitive and neuropsychological functioning, structural and functional magnetic resonance imaging (MRI), along with diffusion tensor imaging (DTI), and a comprehensive magnetoencephalography battery (MEG). In addition, blood samples of healthy volunteers are banked for future analyses. All data collected in this protocol are broadly shared in the OpenNeuro repository, in the Brain Imaging Data Structure (BIDS) format. In addition, task paradigms and basic pre-processing scripts are shared on GitHub. There are currently few open access MEG datasets, and multimodal neuroimaging datasets are even more rare. Due to its depth of characterization of a healthy population in terms of brain health, this dataset may contribute to a wide array of secondary investigations of non-clinical and clinical research questions.

21 January 2024 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
JSJacob S. Shaw
Jacob S. Shaw
JLJeannie M. Leoutsakos
Jeannie M. Leoutsakos
PRPaul B. Rosenberg
Paul B. Rosenberg

1 November 2022 in International Journal of Methods in Psychiatric Research
Verified
Journal Article
Open access
AGAlison B. Gibbons
Alison B. Gibbons
CFCristan Farmer
Cristan Farmer
JSJacob S. Shaw
Jacob S. Shaw
JCJoyce Y. Chung
Joyce Y. Chung
Objectives: The DSM‐5 Level 1 Cross‐Cutting Symptom Measure (DSM‐XC) was developed by the American Psychiatric Association as a transdiagnostic mental health symptom survey. Despite its promise as a screening tool, few studies have assessed its latent dimensionality or provided guidance on interpreting responses. We examined the factor structure of the DSM‐XC in a convenience sample of participants with varying degrees of psychopathology.Methods: Participants (n = 3533) were enrolled in an online study on the mental health impact of COVID‐19 (NCT04339790). We used a factor analytic framework with exploratory and confirmatory analyses to evaluate candidate factor solutions. Convergent validity analysis with concurrent study measures was also performed.Results: Six‐factor and bifactor candidate solutions both had good fit and full measurement invariance across age, sex, and enrollment date. The six‐factor solution resulted in constructs labeled as: mood, worry, activation, somatic, thought, and substance use. A general psychopathology factor and two residual factors (mood and anxiety constructs) explained the variance of the bifactor solution.Conclusions: Our analysis supports that the DSM‐XC is a multidimensional instrument spanning many mental health symptoms. We provide scoring solutions for two factor structures that capture broader constructs of psychopathology. Use of a convenience sample may limit generalizability of findings.

9 January 2025 in Nature Mental Health
Verified
Journal Article
Open access
PDF file
LALauren Y. Atlas
Lauren Y. Atlas
CFCristan Farmer
Cristan Farmer
JSJacob S. Shaw
Jacob S. Shaw
AGAlison Gibbons
Alison Gibbons
EGEmily P. Guinee
Emily P. Guinee
JCJoyce Y. Chung
Joyce Y. Chung
The COVID-19 pandemic’s impact on mental health is challenging to quantify because pre-existing risk, disease burden and public policy varied across individuals, time and regions. Longitudinal, within-person analyses can determine whether pandemic-related changes in social isolation impacted mental health. We analyzed time-varying associations between psychiatric vulnerability, loneliness, psychological distress and social distancing in a US-based study during the first year of the pandemic. We surveyed 3,655 participants about psychological health and COVID-19-related circumstances every 2 weeks for 6 months. We combined self-reports with regional social distancing estimates and a classifier that predicted probability of psychiatric diagnosis at enrollment. Loneliness and psychiatric vulnerability both impacted psychological distress. Loneliness and distress were also linked to social isolation and stress associated with distancing, and psychiatric vulnerability shaped how regional distancing affected loneliness across time. Public health policies should address loneliness when encouraging social distancing, particularly in those at risk for psychiatric conditions.

27 March 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
JSJacob S. Shaw
Jacob S. Shaw
PHPhilip C. Huang
Philip C. Huang
PRPaul B. Rosenberg
Paul B. Rosenberg
MPMatthew E. Peters
Matthew E. Peters
INTRODUCTION: Motor symptoms may present throughout the Alzheimer's disease (AD) course. We evaluated the impact of motor symptoms on the risk of progression to severe cognitive impairment, severe neuropsychiatric symptoms (NPSs), and mortality in patients with autopsy‐confirmed AD. We also examined the rates of non‐AD pathology and identified the predictors of disease progression among these patients.METHODS: Data from the National Alzheimer's Coordinating Center (NACC) were used for this analysis. Participants (N = 1167) were required to have autopsy‐confirmed AD.RESULTS: Motor symptoms were predictive of progression to severe cognitive impairment but not progression to severe NPSs or death. Presenting with gait disturbance and slowness but not falls or tremor was predictive of progression to severe cognitive impairment. Patients with motor symptoms had higher rates of Lewy body disease pathology on autopsy.DISCUSSION: Our findings suggest that the presence of motor symptoms in autopsy‐confirmed AD, particularly gait disturbance and slowness, are predictive of more rapid cognitive decline.Highlights: Clinician‐defined motor symptoms in patients with Alzheimer's disease (AD) predicted more rapid progression to severe cognitive impairment but not to severe neuropsychiatric symptoms (NPSs) or death. Among AD patients with motor symptoms, presenting with gait disturbance and slowness was predictive of progression to severe cognitive impairment, whereas presenting with falls and tremor was not predictive of progression to severe cognitive impairment. Patients with motor symptoms, particularly gait disturbance and slowness, had higher rates of comorbid Lewy body disease pathology.